
A new study from the Johns Hopkins Arthritis Center reveals that cigarette smoking is not linked to the development of antibodies to PAD4 in patients with severe rheumatoid arthritis.

For too long, doctors treating rheumatic diseases have had to base their management on instinct and experience.
The problem is that each physician has a limited experience – which means that many times we basically had to guess at how to treat a specific patient, using trial and error to find out what might work best.